EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    6.1.1.11 | Deafness |
10764807 |
Characterization and tRNA recognition of mammalian mitochondrial seryl-tRNA synthetase. |
unassigned |
0 |
| 6.1.1.11 | Deafness |
11317363 |
Novel coding-region polymorphisms in mitochondrial seryl-tRNA synthetase (SARSM) and mitoribosomal protein S12 (RPMS12) genes in DFNA4 autosomal dominant deafness families. |
unassigned |
0 |
| 6.1.1.11 | Glioblastoma |
27279902 |
High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe. |
causal interaction
unassigned |
2
0 |
| 6.1.1.11 | Glioblastoma |
28569328 |
An EGFRvIII targeted dual-modal gold nanoprobe for imaging-guided brain tumor surgery. |
causal interaction
unassigned |
4
0 |
| 6.1.1.11 | Hypertension, Pulmonary |
21255763 |
Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. |
causal interaction
unassigned |
4
0 |
| 6.1.1.11 | Hypertension, Pulmonary |
27279129 |
Splicing Defect in Mitochondrial Seryl-tRNA Synthetase Gene Causes Progressive Spastic Paresis Instead of HUPRA Syndrome. |
causal interaction
unassigned |
4
0 |
| 6.1.1.11 | Infections |
18810282 |
SERRS immunoassay for quantitative human CRP analysis. |
diagnostic usage
therapeutic application
unassigned |
4
1
0 |
| 6.1.1.11 | Liver Diseases |
31349478 |
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
2
3
1 |
| 6.1.1.11 | Liver Neoplasms |
31349478 |
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
2
3
1 |
| 6.1.1.11 | Lymphatic Metastasis |
26943129 |
Detection of Lymph Node Metastases with SERRS Nanoparticles. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
4
1
0 |
